APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Contaminants Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Contaminants Detection and Analysis Industry Growth and Trends Forecast to 2032

4 June 2026121 pages

Choose your research edition.

Industry ResearchDrug Contaminants Detection and Analysis Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Contaminants Detection and Analysis Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Contaminants Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Contaminants Detection and Analysis Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Contaminants Detection and Analysis Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug Contaminants Detection and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Contaminants Detection and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Contaminants Detection and Analysis market include Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek (UK), Thermo Fisher Scientific (USA), Charles River Laboratories (USA), Labcorp Biopharma (USA), WuXi STA / WuXi AppTec (China), Cambrex (USA) and Pharmaron (China), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Contaminants Detection and Analysis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Contaminants Detection and Analysis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Contaminants Detection and Analysis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Contaminants Detection and Analysis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Contaminants Detection and Analysis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Contaminants Detection and Analysis Market by Company

Eurofins Scientific (Luxembourg)

SGS (Switzerland)

Intertek (UK)

Thermo Fisher Scientific (USA)

Charles River Laboratories (USA)

Labcorp Biopharma (USA)

WuXi STA / WuXi AppTec (China)

Cambrex (USA)

Pharmaron (China)

Piramal Pharma Solutions (India)

Syngene (India)

Recipharm (Sweden)

Almac Sciences (UK)

MedPharm (UK)

CMIC (Japan)

Aenova (Germany)

Sterling Pharma Solutions (UK)

Curia (USA)

Ardena (Belgium)

Hovione (Portugal)

Delpharm (France)

AGC Biologics (USA)

FUJIFILM Biotechnologies (Japan)

KBI Biopharma (USA)

Rentschler Biopharma (Germany)

Ajinomoto Bio-Pharma Services (Japan)

Bora Pharmaceuticals (Taiwan, China)

Kindeva (USA)

CordenPharma (Switzerland)

RSSL (UK)

Tentamus (Germany)

Element Materials Technology (UK)

Nucro-Technics (Canada)

ALS (Australia)

Aizant (India)

Wickham Laboratories (UK)

Toxikon (USA)

Evotec (Germany)

Drug Contaminants Detection and Analysis Segment by Type

Organic Pollutant Detection Products

Inorganic Pollutant Detection Products

Others

Drug Contaminants Detection and Analysis Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Traditional Chinese Medicine and Natural Medicine Industry

Others

Drug Contaminants Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Contaminants Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Contaminants Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Contaminants Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Contaminants Detection and Analysis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Contaminants Detection and Analysis Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Contaminants Detection and Analysis Market Share by Region (2021-2026) Table 4. Global Drug Contaminants Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Contaminants Detection and Analysis Market Share by Region (2027-2032) Table 6. Global Drug Contaminants Detection and Analysis Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Contaminants Detection and Analysis Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2026) Table 9. Global Drug Contaminants Detection and Analysis Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Contaminants Detection and Analysis Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Contaminants Detection and Analysis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Contaminants Detection and Analysis Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2026) Table 24. Global Drug Contaminants Detection and Analysis Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Contaminants Detection and Analysis Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Contaminants Detection and Analysis Industry Trends Table 37. Drug Contaminants Detection and Analysis Industry Drivers Table 38. Drug Contaminants Detection and Analysis Industry Opportunities and Challenges Table 39. Drug Contaminants Detection and Analysis Industry Restraints Table 40. Global Drug Contaminants Detection and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Contaminants Detection and Analysis Revenue Market Share by Company (2021-2026) Table 42. Global Drug Contaminants Detection and Analysis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Contaminants Detection and Analysis Key Company Headquarters & Area Served Table 44. Global Drug Contaminants Detection and Analysis Company, Product Type & Application Table 45. Global Drug Contaminants Detection and Analysis Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Contaminants Detection and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Eurofins Scientific (Luxembourg) Company Information Table 49. Eurofins Scientific (Luxembourg) Business Overview Table 50. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio Table 52. Eurofins Scientific (Luxembourg) Recent Development Table 53. SGS (Switzerland) Company Information Table 54. SGS (Switzerland) Business Overview Table 55. SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 57. SGS (Switzerland) Recent Development Table 58. Intertek (UK) Company Information Table 59. Intertek (UK) Business Overview Table 60. Intertek (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 62. Intertek (UK) Recent Development Table 63. Thermo Fisher Scientific (USA) Company Information Table 64. Thermo Fisher Scientific (USA) Business Overview Table 65. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 67. Thermo Fisher Scientific (USA) Recent Development Table 68. Charles River Laboratories (USA) Company Information Table 69. Charles River Laboratories (USA) Business Overview Table 70. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 72. Charles River Laboratories (USA) Recent Development Table 73. Labcorp Biopharma (USA) Company Information Table 74. Labcorp Biopharma (USA) Business Overview Table 75. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 77. Labcorp Biopharma (USA) Recent Development Table 78. WuXi STA / WuXi AppTec (China) Company Information Table 79. WuXi STA / WuXi AppTec (China) Business Overview Table 80. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio Table 82. WuXi STA / WuXi AppTec (China) Recent Development Table 83. Cambrex (USA) Company Information Table 84. Cambrex (USA) Business Overview Table 85. Cambrex (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 87. Cambrex (USA) Recent Development Table 88. Pharmaron (China) Company Information Table 89. Pharmaron (China) Business Overview Table 90. Pharmaron (China) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio Table 92. Pharmaron (China) Recent Development Table 93. Piramal Pharma Solutions (India) Company Information Table 94. Piramal Pharma Solutions (India) Business Overview Table 95. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio Table 97. Piramal Pharma Solutions (India) Recent Development Table 98. Syngene (India) Company Information Table 99. Syngene (India) Business Overview Table 100. Syngene (India) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio Table 102. Syngene (India) Recent Development Table 103. Recipharm (Sweden) Company Information Table 104. Recipharm (Sweden) Business Overview Table 105. Recipharm (Sweden) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio Table 107. Recipharm (Sweden) Recent Development Table 108. Almac Sciences (UK) Company Information Table 109. Almac Sciences (UK) Business Overview Table 110. Almac Sciences (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 112. Almac Sciences (UK) Recent Development Table 113. MedPharm (UK) Company Information Table 114. MedPharm (UK) Business Overview Table 115. MedPharm (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 117. MedPharm (UK) Recent Development Table 118. CMIC (Japan) Company Information Table 119. CMIC (Japan) Business Overview Table 120. CMIC (Japan) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 122. CMIC (Japan) Recent Development Table 123. Aenova (Germany) Company Information Table 124. Aenova (Germany) Business Overview Table 125. Aenova (Germany) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 127. Aenova (Germany) Recent Development Table 128. Sterling Pharma Solutions (UK) Company Information Table 129. Sterling Pharma Solutions (UK) Business Overview Table 130. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 132. Sterling Pharma Solutions (UK) Recent Development Table 133. Curia (USA) Company Information Table 134. Curia (USA) Business Overview Table 135. Curia (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 137. Curia (USA) Recent Development Table 138. Ardena (Belgium) Company Information Table 139. Ardena (Belgium) Business Overview Table 140. Ardena (Belgium) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio Table 142. Ardena (Belgium) Recent Development Table 143. Hovione (Portugal) Company Information Table 144. Hovione (Portugal) Business Overview Table 145. Hovione (Portugal) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio Table 147. Hovione (Portugal) Recent Development Table 148. Delpharm (France) Company Information Table 149. Delpharm (France) Business Overview Table 150. Delpharm (France) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio Table 152. Delpharm (France) Recent Development Table 153. AGC Biologics (USA) Company Information Table 154. AGC Biologics (USA) Business Overview Table 155. AGC Biologics (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 157. AGC Biologics (USA) Recent Development Table 158. FUJIFILM Biotechnologies (Japan) Company Information Table 159. FUJIFILM Biotechnologies (Japan) Business Overview Table 160. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 162. FUJIFILM Biotechnologies (Japan) Recent Development Table 163. KBI Biopharma (USA) Company Information Table 164. KBI Biopharma (USA) Business Overview Table 165. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 167. KBI Biopharma (USA) Recent Development Table 168. Rentschler Biopharma (Germany) Company Information Table 169. Rentschler Biopharma (Germany) Business Overview Table 170. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 172. Rentschler Biopharma (Germany) Recent Development Table 173. Ajinomoto Bio-Pharma Services (Japan) Company Information Table 174. Ajinomoto Bio-Pharma Services (Japan) Business Overview Table 175. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 177. Ajinomoto Bio-Pharma Services (Japan) Recent Development Table 178. Bora Pharmaceuticals (Taiwan, China) Company Information Table 179. Bora Pharmaceuticals (Taiwan, China) Business Overview Table 180. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio Table 182. Bora Pharmaceuticals (Taiwan, China) Recent Development Table 183. Kindeva (USA) Company Information Table 184. Kindeva (USA) Business Overview Table 185. Kindeva (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 187. Kindeva (USA) Recent Development Table 188. CordenPharma (Switzerland) Company Information Table 189. CordenPharma (Switzerland) Business Overview Table 190. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 192. CordenPharma (Switzerland) Recent Development Table 193. RSSL (UK) Company Information Table 194. RSSL (UK) Business Overview Table 195. RSSL (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 197. RSSL (UK) Recent Development Table 198. Tentamus (Germany) Company Information Table 199. Tentamus (Germany) Business Overview Table 200. Tentamus (Germany) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 201. Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 202. Tentamus (Germany) Recent Development Table 203. Element Materials Technology (UK) Company Information Table 204. Element Materials Technology (UK) Business Overview Table 205. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 206. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 207. Element Materials Technology (UK) Recent Development Table 208. Nucro-Technics (Canada) Company Information Table 209. Nucro-Technics (Canada) Business Overview Table 210. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 211. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio Table 212. Nucro-Technics (Canada) Recent Development Table 213. ALS (Australia) Company Information Table 214. ALS (Australia) Business Overview Table 215. ALS (Australia) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 216. ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio Table 217. ALS (Australia) Recent Development Table 218. Aizant (India) Company Information Table 219. Aizant (India) Business Overview Table 220. Aizant (India) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 221. Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio Table 222. Aizant (India) Recent Development Table 223. Wickham Laboratories (UK) Company Information Table 224. Wickham Laboratories (UK) Business Overview Table 225. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 226. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 227. Wickham Laboratories (UK) Recent Development Table 228. Toxikon (USA) Company Information Table 229. Toxikon (USA) Business Overview Table 230. Toxikon (USA) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 231. Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 232. Toxikon (USA) Recent Development Table 233. Evotec (Germany) Company Information Table 234. Evotec (Germany) Business Overview Table 235. Evotec (Germany) Drug Contaminants Detection and Analysis Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 236. Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 237. Evotec (Germany) Recent Development Table 238. North America Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 239. North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 240. North America Drug Contaminants Detection and Analysis Market Share by Country (2021-2026) Table 241. North America Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 242. North America Drug Contaminants Detection and Analysis Market Share Forecast by Country (2027-2032) Table 243. Europe Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 244. Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 245. Europe Drug Contaminants Detection and Analysis Market Share by Country (2021-2026) Table 246. Europe Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 247. Europe Drug Contaminants Detection and Analysis Market Share Forecast by Country (2027-2032) Table 248. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 249. Asia-Pacific Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 250. Asia-Pacific Drug Contaminants Detection and Analysis Market Share by Country (2021-2026) Table 251. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 252. Asia-Pacific Drug Contaminants Detection and Analysis Market Share Forecast by Country (2027-2032) Table 253. Latin America Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Latin America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 255. Latin America Drug Contaminants Detection and Analysis Market Share by Country (2021-2026) Table 256. Latin America Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Latin America Drug Contaminants Detection and Analysis Market Share Forecast by Country (2027-2032) Table 258. Middle East & Africa Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 259. Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026) & (US$ Million) Table 260. Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Country (2021-2026) Table 261. Middle East & Africa Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 262. Middle East & Africa Drug Contaminants Detection and Analysis Market Share Forecast by Country (2027-2032) Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Contaminants Detection and Analysis Product Image Figure 3. Global Drug Contaminants Detection and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Contaminants Detection and Analysis Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Contaminants Detection and Analysis Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Contaminants Detection and Analysis Market Share by Region (2021-2032) Figure 7. North America Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Organic Pollutant Detection Products Image Figure 13. Global Organic Pollutant Detection Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Inorganic Pollutant Detection Products Image Figure 15. Global Inorganic Pollutant Detection Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Drug Contaminants Detection and Analysis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Drug Contaminants Detection and Analysis Market Share by Type 2025 VS 2032 Figure 20. North America Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032) Figure 21. Europe Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032) Figure 23. Latin America Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Share by Type (2021-2032) Figure 25. Chemical Pharmaceutical Industry Image Figure 26. Global Chemical Pharmaceutical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Biopharmaceutical Industry Image Figure 28. Global Biopharmaceutical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Traditional Chinese Medicine and Natural Medicine Industry Image Figure 30. Global Traditional Chinese Medicine and Natural Medicine Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Drug Contaminants Detection and Analysis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Drug Contaminants Detection and Analysis Market Share by Application 2025 VS 2032 Figure 35. North America Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032) Figure 36. Europe Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032) Figure 38. Latin America Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Drug Contaminants Detection and Analysis Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Drug Contaminants Detection and Analysis Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Drug Contaminants Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Drug Contaminants Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 45. Europe Drug Contaminants Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Drug Contaminants Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 48. Asia-Pacific Drug Contaminants Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Drug Contaminants Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 51. Latin America Drug Contaminants Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Drug Contaminants Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 54. Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Drug Contaminants Detection and Analysis Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Pollutant Detection Products
  • Inorganic Pollutant Detection Products
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Traditional Chinese Medicine and Natural Medicine Industry
  • Others
Companies covered
  • Eurofins Scientific (Luxembourg)
  • SGS (Switzerland)
  • Intertek (UK)
  • Thermo Fisher Scientific (USA)
  • Charles River Laboratories (USA)
  • Labcorp Biopharma (USA)
  • WuXi STA / WuXi AppTec (China)
  • Cambrex (USA)
  • Pharmaron (China)
  • Piramal Pharma Solutions (India)
  • Syngene (India)
  • Recipharm (Sweden)
  • Almac Sciences (UK)
  • MedPharm (UK)
  • CMIC (Japan)
  • Aenova (Germany)
  • Sterling Pharma Solutions (UK)
  • Curia (USA)
  • Ardena (Belgium)
  • Hovione (Portugal)
  • Delpharm (France)
  • AGC Biologics (USA)
  • FUJIFILM Biotechnologies (Japan)
  • KBI Biopharma (USA)
  • Rentschler Biopharma (Germany)
  • Ajinomoto Bio-Pharma Services (Japan)
  • Bora Pharmaceuticals (Taiwan, China)
  • Kindeva (USA)
  • CordenPharma (Switzerland)
  • RSSL (UK)
  • Tentamus (Germany)
  • Element Materials Technology (UK)
  • Nucro-Technics (Canada)
  • ALS (Australia)
  • Aizant (India)
  • Wickham Laboratories (UK)
  • Toxikon (USA)
  • Evotec (Germany)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Contaminants Detection and Analysis Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Contaminants Detection and Analysis Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Contaminants Detection and Analysis Market Size (2021-2032)
  8. 1.5.1 North America Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Contaminants Detection and Analysis Market Size Growth Rate (2021-2032)
2 Drug Contaminants Detection and Analysis Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Organic Pollutant Detection Products
  3. 2.1.2 Inorganic Pollutant Detection Products
  4. 2.1.3 Others
  5. 2.2 Global Drug Contaminants Detection and Analysis Market Size by Type
  6. 2.2.1 Global Drug Contaminants Detection and Analysis Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Drug Contaminants Detection and Analysis Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Drug Contaminants Detection and Analysis Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Drug Contaminants Detection and Analysis Market Size by Regions
  10. 2.3.1 North America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Type (2021-2026)
3 Drug Contaminants Detection and Analysis Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Chemical Pharmaceutical Industry
  3. 3.1.2 Biopharmaceutical Industry
  4. 3.1.3 Traditional Chinese Medicine and Natural Medicine Industry
  5. 3.1.4 Others
  6. 3.2 Global Drug Contaminants Detection and Analysis Market Size by Application
  7. 3.2.1 Global Drug Contaminants Detection and Analysis Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drug Contaminants Detection and Analysis Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drug Contaminants Detection and Analysis Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drug Contaminants Detection and Analysis Market Size by Regions
  11. 3.3.1 North America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drug Contaminants Detection and Analysis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Contaminants Detection and Analysis Industry Trends
  2. 4.2 Drug Contaminants Detection and Analysis Industry Drivers
  3. 4.3 Drug Contaminants Detection and Analysis Industry Opportunities and Challenges
  4. 4.4 Drug Contaminants Detection and Analysis Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Contaminants Detection and Analysis Revenue (2021-2026)
  2. 5.2 Global Drug Contaminants Detection and Analysis Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Contaminants Detection and Analysis Key Company Headquarters & Area Served
  4. 5.4 Global Drug Contaminants Detection and Analysis Company, Product Type & Application
  5. 5.5 Global Drug Contaminants Detection and Analysis Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Contaminants Detection and Analysis Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Contaminants Detection and Analysis Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Contaminants Detection and Analysis Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Eurofins Scientific (Luxembourg)
  2. 6.1.1 Eurofins Scientific (Luxembourg) Company Information
  3. 6.1.2 Eurofins Scientific (Luxembourg) Business Overview
  4. 6.1.3 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio
  6. 6.1.5 Eurofins Scientific (Luxembourg) Recent Developments
  7. 6.2 SGS (Switzerland)
  8. 6.2.1 SGS (Switzerland) Company Information
  9. 6.2.2 SGS (Switzerland) Business Overview
  10. 6.2.3 SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  12. 6.2.5 SGS (Switzerland) Recent Developments
  13. 6.3 Intertek (UK)
  14. 6.3.1 Intertek (UK) Company Information
  15. 6.3.2 Intertek (UK) Business Overview
  16. 6.3.3 Intertek (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio
  18. 6.3.5 Intertek (UK) Recent Developments
  19. 6.4 Thermo Fisher Scientific (USA)
  20. 6.4.1 Thermo Fisher Scientific (USA) Company Information
  21. 6.4.2 Thermo Fisher Scientific (USA) Business Overview
  22. 6.4.3 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific (USA) Recent Developments
  25. 6.5 Charles River Laboratories (USA)
  26. 6.5.1 Charles River Laboratories (USA) Company Information
  27. 6.5.2 Charles River Laboratories (USA) Business Overview
  28. 6.5.3 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio
  30. 6.5.5 Charles River Laboratories (USA) Recent Developments
  31. 6.6 Labcorp Biopharma (USA)
  32. 6.6.1 Labcorp Biopharma (USA) Company Information
  33. 6.6.2 Labcorp Biopharma (USA) Business Overview
  34. 6.6.3 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  36. 6.6.5 Labcorp Biopharma (USA) Recent Developments
  37. 6.7 WuXi STA / WuXi AppTec (China)
  38. 6.7.1 WuXi STA / WuXi AppTec (China) Company Information
  39. 6.7.2 WuXi STA / WuXi AppTec (China) Business Overview
  40. 6.7.3 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio
  42. 6.7.5 WuXi STA / WuXi AppTec (China) Recent Developments
  43. 6.8 Cambrex (USA)
  44. 6.8.1 Cambrex (USA) Company Information
  45. 6.8.2 Cambrex (USA) Business Overview
  46. 6.8.3 Cambrex (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio
  48. 6.8.5 Cambrex (USA) Recent Developments
  49. 6.9 Pharmaron (China)
  50. 6.9.1 Pharmaron (China) Company Information
  51. 6.9.2 Pharmaron (China) Business Overview
  52. 6.9.3 Pharmaron (China) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio
  54. 6.9.5 Pharmaron (China) Recent Developments
  55. 6.10 Piramal Pharma Solutions (India)
  56. 6.10.1 Piramal Pharma Solutions (India) Company Information
  57. 6.10.2 Piramal Pharma Solutions (India) Business Overview
  58. 6.10.3 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions (India) Recent Developments
  61. 6.11 Syngene (India)
  62. 6.11.1 Syngene (India) Company Information
  63. 6.11.2 Syngene (India) Business Overview
  64. 6.11.3 Syngene (India) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio
  66. 6.11.5 Syngene (India) Recent Developments
  67. 6.12 Recipharm (Sweden)
  68. 6.12.1 Recipharm (Sweden) Company Information
  69. 6.12.2 Recipharm (Sweden) Business Overview
  70. 6.12.3 Recipharm (Sweden) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio
  72. 6.12.5 Recipharm (Sweden) Recent Developments
  73. 6.13 Almac Sciences (UK)
  74. 6.13.1 Almac Sciences (UK) Company Information
  75. 6.13.2 Almac Sciences (UK) Business Overview
  76. 6.13.3 Almac Sciences (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio
  78. 6.13.5 Almac Sciences (UK) Recent Developments
  79. 6.14 MedPharm (UK)
  80. 6.14.1 MedPharm (UK) Company Information
  81. 6.14.2 MedPharm (UK) Business Overview
  82. 6.14.3 MedPharm (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio
  84. 6.14.5 MedPharm (UK) Recent Developments
  85. 6.15 CMIC (Japan)
  86. 6.15.1 CMIC (Japan) Company Information
  87. 6.15.2 CMIC (Japan) Business Overview
  88. 6.15.3 CMIC (Japan) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  90. 6.15.5 CMIC (Japan) Recent Developments
  91. 6.16 Aenova (Germany)
  92. 6.16.1 Aenova (Germany) Company Information
  93. 6.16.2 Aenova (Germany) Business Overview
  94. 6.16.3 Aenova (Germany) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  96. 6.16.5 Aenova (Germany) Recent Developments
  97. 6.17 Sterling Pharma Solutions (UK)
  98. 6.17.1 Sterling Pharma Solutions (UK) Company Information
  99. 6.17.2 Sterling Pharma Solutions (UK) Business Overview
  100. 6.17.3 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio
  102. 6.17.5 Sterling Pharma Solutions (UK) Recent Developments
  103. 6.18 Curia (USA)
  104. 6.18.1 Curia (USA) Company Information
  105. 6.18.2 Curia (USA) Business Overview
  106. 6.18.3 Curia (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio
  108. 6.18.5 Curia (USA) Recent Developments
  109. 6.19 Ardena (Belgium)
  110. 6.19.1 Ardena (Belgium) Company Information
  111. 6.19.2 Ardena (Belgium) Business Overview
  112. 6.19.3 Ardena (Belgium) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio
  114. 6.19.5 Ardena (Belgium) Recent Developments
  115. 6.20 Hovione (Portugal)
  116. 6.20.1 Hovione (Portugal) Company Information
  117. 6.20.2 Hovione (Portugal) Business Overview
  118. 6.20.3 Hovione (Portugal) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio
  120. 6.20.5 Hovione (Portugal) Recent Developments
  121. 6.21 Delpharm (France)
  122. 6.21.1 Delpharm (France) Company Information
  123. 6.21.2 Delpharm (France) Business Overview
  124. 6.21.3 Delpharm (France) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio
  126. 6.21.5 Delpharm (France) Recent Developments
  127. 6.22 AGC Biologics (USA)
  128. 6.22.1 AGC Biologics (USA) Company Information
  129. 6.22.2 AGC Biologics (USA) Business Overview
  130. 6.22.3 AGC Biologics (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio
  132. 6.22.5 AGC Biologics (USA) Recent Developments
  133. 6.23 FUJIFILM Biotechnologies (Japan)
  134. 6.23.1 FUJIFILM Biotechnologies (Japan) Company Information
  135. 6.23.2 FUJIFILM Biotechnologies (Japan) Business Overview
  136. 6.23.3 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  138. 6.23.5 FUJIFILM Biotechnologies (Japan) Recent Developments
  139. 6.24 KBI Biopharma (USA)
  140. 6.24.1 KBI Biopharma (USA) Company Information
  141. 6.24.2 KBI Biopharma (USA) Business Overview
  142. 6.24.3 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  144. 6.24.5 KBI Biopharma (USA) Recent Developments
  145. 6.25 Rentschler Biopharma (Germany)
  146. 6.25.1 Rentschler Biopharma (Germany) Company Information
  147. 6.25.2 Rentschler Biopharma (Germany) Business Overview
  148. 6.25.3 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  150. 6.25.5 Rentschler Biopharma (Germany) Recent Developments
  151. 6.26 Ajinomoto Bio-Pharma Services (Japan)
  152. 6.26.1 Ajinomoto Bio-Pharma Services (Japan) Company Information
  153. 6.26.2 Ajinomoto Bio-Pharma Services (Japan) Business Overview
  154. 6.26.3 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  156. 6.26.5 Ajinomoto Bio-Pharma Services (Japan) Recent Developments
  157. 6.27 Bora Pharmaceuticals (Taiwan, China)
  158. 6.27.1 Bora Pharmaceuticals (Taiwan, China) Company Information
  159. 6.27.2 Bora Pharmaceuticals (Taiwan, China) Business Overview
  160. 6.27.3 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio
  162. 6.27.5 Bora Pharmaceuticals (Taiwan, China) Recent Developments
  163. 6.28 Kindeva (USA)
  164. 6.28.1 Kindeva (USA) Company Information
  165. 6.28.2 Kindeva (USA) Business Overview
  166. 6.28.3 Kindeva (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio
  168. 6.28.5 Kindeva (USA) Recent Developments
  169. 6.29 CordenPharma (Switzerland)
  170. 6.29.1 CordenPharma (Switzerland) Company Information
  171. 6.29.2 CordenPharma (Switzerland) Business Overview
  172. 6.29.3 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  174. 6.29.5 CordenPharma (Switzerland) Recent Developments
  175. 6.30 RSSL (UK)
  176. 6.30.1 RSSL (UK) Company Information
  177. 6.30.2 RSSL (UK) Business Overview
  178. 6.30.3 RSSL (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio
  180. 6.30.5 RSSL (UK) Recent Developments
  181. 6.31 Tentamus (Germany)
  182. 6.31.1 Tentamus (Germany) Company Information
  183. 6.31.2 Tentamus (Germany) Business Overview
  184. 6.31.3 Tentamus (Germany) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  185. 6.31.4 Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  186. 6.31.5 Tentamus (Germany) Recent Developments
  187. 6.32 Element Materials Technology (UK)
  188. 6.32.1 Element Materials Technology (UK) Company Information
  189. 6.32.2 Element Materials Technology (UK) Business Overview
  190. 6.32.3 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  191. 6.32.4 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio
  192. 6.32.5 Element Materials Technology (UK) Recent Developments
  193. 6.33 Nucro-Technics (Canada)
  194. 6.33.1 Nucro-Technics (Canada) Company Information
  195. 6.33.2 Nucro-Technics (Canada) Business Overview
  196. 6.33.3 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  197. 6.33.4 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio
  198. 6.33.5 Nucro-Technics (Canada) Recent Developments
  199. 6.34 ALS (Australia)
  200. 6.34.1 ALS (Australia) Company Information
  201. 6.34.2 ALS (Australia) Business Overview
  202. 6.34.3 ALS (Australia) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  203. 6.34.4 ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio
  204. 6.34.5 ALS (Australia) Recent Developments
  205. 6.35 Aizant (India)
  206. 6.35.1 Aizant (India) Company Information
  207. 6.35.2 Aizant (India) Business Overview
  208. 6.35.3 Aizant (India) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  209. 6.35.4 Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio
  210. 6.35.5 Aizant (India) Recent Developments
  211. 6.36 Wickham Laboratories (UK)
  212. 6.36.1 Wickham Laboratories (UK) Company Information
  213. 6.36.2 Wickham Laboratories (UK) Business Overview
  214. 6.36.3 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  215. 6.36.4 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio
  216. 6.36.5 Wickham Laboratories (UK) Recent Developments
  217. 6.37 Toxikon (USA)
  218. 6.37.1 Toxikon (USA) Company Information
  219. 6.37.2 Toxikon (USA) Business Overview
  220. 6.37.3 Toxikon (USA) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  221. 6.37.4 Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio
  222. 6.37.5 Toxikon (USA) Recent Developments
  223. 6.38 Evotec (Germany)
  224. 6.38.1 Evotec (Germany) Company Information
  225. 6.38.2 Evotec (Germany) Business Overview
  226. 6.38.3 Evotec (Germany) Drug Contaminants Detection and Analysis Revenue, Global Share and Gross Margin (2021-2026)
  227. 6.38.4 Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  228. 6.38.5 Evotec (Germany) Recent Developments
7 North America
  1. 7.1 North America Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  3. 7.3 North America Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  3. 10.3 South America Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Contaminants Detection and Analysis Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Contaminants Detection and Analysis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst